Live Breaking News & Updates on Pierluigi Antonelli

Stay updated with breaking news from Pierluigi antonelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fresenius : Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board

Contact

Nicole Weber

T +49 6172 686-2394
nicole.weber@fresenius.com

Documents
. ....

Baden Wüberg , Bad Homburg , United States , Soult Ukpyolsi , South Korea , Pierluigi Antonelli , Michael Sen , Nicole Weber , Samsung Bioepis , Fresenius Kabi , Jin Pak , Johannes Gutenberg University Mainz , Fresenius Medical Care , Sang Jin Pak , Michael Sch , Fresenius Kabi Management Board , Supervisory Board , Fresenius Kabi Supervisory Board , Fresenius Management , Fresenius Medical , Middle East , Latin America , Executive Vice President , Global Commercial , Managing Director ,

BIAL appoints Pierluigi Antonelli as Non-Executive Board Member

Porto, April 24, 2024 - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurology, has announced the appointment of Pierluigi Antonelli, Fresenius Management Board member and Chairman & CEO of Fresenius Kabi, as a non-executive member of its Board of Directors. Antonio Horta-. ....

Coted Ivoire , United States , United Kingdom , Ivory Coast , Pierluigi Antonelli , Libera Universit , Fresenius Kabi , Antonio Horta Osorio , Bristol Myers Squibb , Angelini Pharma , Merck Co , Life Sciences , Kellogg School Of Management , Fresenius Management Board , Generic Drugs , Novartis Oncology , Kellogg School , Studi Sociali ,

FDA approves second tocilizumab biosimilar; first available in IV, subcutaneous forms

FDA approves second tocilizumab biosimilar; first available in IV, subcutaneous forms
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Shenaz Bagha , Fresenius Kabi , Pierluigi Antonelli ,

Fresenius debuts Actemra biosimilar

Tyenne, for use in the treatment of chronic autoimmune diseases, is available in an intravenous formulation. ....

Bio Pharma , Michael Sen , Pierluigi Antonelli , Fresenius Kabi ,

European Commission Approves First Tocilizumab Biosimilar

The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19. ....

Fresenius Kabi , Pierluigi Antonelli , Drug Administration , European Medicines Agency , European Commission , European Union , Chief Executive Officer Pierluigi Antonelli , Biologic License Application , Rheumatoid Arthritis , Biologic Therapy , Biosimilar Drugs , Follow On Biologics , Interleukin Antagonist , L Antagonist , Covid 19 Treatment , Juvenile Rheumatoid Arthritis , Oint Inflammation , Chimeric Antigen Receptort Cell Therapy , Chimeric Antigen Receptors , Himeric Immunoreceptors , Himerict Cell Receptors , Rtificialt Cell Receptors , Ar T , Alternative Med ,